Literature DB >> 2202245

Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.

A Torres1, R Aznar, J M Gatell, P Jiménez, J González, A Ferrer, R Celis, R Rodriguez-Roisin.   

Abstract

Seventy-eight (24%) episodes of nosocomial pneumonia (NP) were detected in 322 consecutive mechanically ventilated patients admitted to a 1,000-bed teaching hospital from April 1987 through May 1988 to assess the incidence, risk, and prognosis factors of NP acquired during mechanical ventilation (MV). The risk and prognosis factors for developing NP during MV were studied using both univariate and multivariate statistical techniques. Multivariate analysis selected the following variables significantly associated with a higher risk for developing ventilator-associated pneumonia: more than one intubation during MV (p = 0.000012), a prior episode of aspiration of gastric content (p = 0.00018), a MV period longer than 3 days (p = 0.015), the presence of chronic obstructive pulmonary disease (COPD) (p = 0.048), and the use of positive end-expiratory pressure (PEEP) during MV (p = 0.092). The presence of an ultimately or rapidly fatal underlying disease (p = 0.0018), worsening of acute respiratory failure caused by pneumonia (p = 0.0096), the presence of septic shock (p = 0.016), an inappropriate antibiotic treatment (p = 0.02), and the type of intensive care unit (ICU) hospitalization (noncardiac surgery and nonsurgical ICU compared with post-cardiac surgery ICU) (p = 0.08) were those factors selected by a stepwise logistic regression analysis as independently worsening the prognosis. The overall fatality rate was 23% (73 of 322). The mortality of patients with NP was higher (33%; 26 of 78; p less than 0.01) when compared with fatality rates of patients without NP (19%; 47 of 244).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2202245     DOI: 10.1164/ajrccm/142.3.523

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  123 in total

Review 1.  Acute respiratory distress syndrome and nosocomial pneumonia.

Authors:  T T Bauer; A Torres
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

Review 2.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Histopathology of ventilator-associated pneumonia (VAP) and its clinical implications.

Authors:  A Torres; N Fábregas; Y Arce; M A López-Boado
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

4.  Benchmarking mechanical ventilation services in teaching hospitals.

Authors:  Pamela V O'Neal; Yasar A Ozcan; Yanqiang Ma
Journal:  J Med Syst       Date:  2002-06       Impact factor: 4.460

Review 5.  Prevention of nosocomial bacterial pneumonia.

Authors:  J L Vincent
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

6.  Outcome of postoperative pneumonia in the Eole study.

Authors:  Hervé Dupont; Philippe Montravers; Rémy Gauzit; Benoît Veber; Jean-Louis Pouriat; Claude Martin
Journal:  Intensive Care Med       Date:  2003-01-14       Impact factor: 17.440

Review 7.  Pulmonary infiltrates in the immunocompromised: diagnosis and management.

Authors:  D Peckham; M W Elliott
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 8.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

9.  Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report.

Authors:  L A Mandell; T J Marrie; M S Niederman
Journal:  Can J Infect Dis       Date:  1993-11

10.  Role of bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia.

Authors:  J Vallés; J Rello; R Fernández; L Blanch; F Baigorri; J Mestre; L Matas; A Marín; A Artigas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.